Valproic acid could help in the fight against COVID-19: A case–control study
Neurologia (Barcelona, Spain)(2022)
摘要
Patients with VPA within the therapeutic range had a reduction of SARS-Cov-2 infection incidence greater than 75%. There is a downward trend in the risk of COVID-19 admission by SARS-CoV-2 in patients on VPA therapy. These findings warrant further investigation.
更多查看译文
关键词
Valproic acid,COVID-19,Incidence,Hospital admission,Spain
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要